Crossmark

Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies

Crossref DOI link: https://doi.org/10.1186/s40959-024-00290-6

Published Online: 2024-12-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Daryanani, Andres E.

Abbasi, Muhannad A.

Gomez Ardila, Maria F.

Tellez-Garcia, Eduardo

Garzon-Dangond, Juan M.

Lin, Yi

Paludo, Jonas

Herrmann, Joerg

Ansell, Stephen M.

Rosenthal, Allison C.

Villarraga, Hector R.
License Information

Text and Data Mining valid from 2024-12-21

Version of Record valid from 2024-12-21
More Information

Article History

Received: 21 June 2024

Accepted: 14 November 2024

First Online: 21 December 2024

Declarations

:

: The Mayo Clinic Institutional Review Board approved this study and waived the requirement for consent.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below